对于抗尿药治疗的高血压,5- 基三胺可能是一个可行的治疗选择
Rachel Kram1, Hannah Garver2, Gregory D Fink2
1Department of Physiology, Michigan State University, East Lansing MI 48824.
American journal of physiology. Heart and circulatory physiology
|August 20, 2025
概括
血素 (5- 三胺,5-HT) 降低了老鼠的血压,即使尿剂是无效的. 这表明5-HT可能是高血压治疗的宝贵补充.
科学领域:
- 心血管生理学
- 药理学
- 肝脏病学
背景情况:
- 在慢性输液中,氨酸 (5- 氨酸,5-HT) 在正常血压和高血压的老鼠中始终降低了平均动脉压 (MAP).
- 达尔-SS大鼠是对盐敏感高血压的模型,并且可能对利尿剂无反应.
研究的目的:
- 为了研究5-HT的降血压效果是否保持在对利尿剂耐药的雄性Dahl-SS大鼠中.
- 评估5-HT作为高血压的辅助疗法的潜力,特别是在尿剂耐药的情况下.
主要方法:
- 雄性Dahl-SS大鼠接受正常或高盐 (4% NaCl) 饮食,并植入放射测量仪以持续监测MAP.
- 通过Alzet迷你给老鼠连续输入5-HT (25毫克/ 千克/ 分钟).
- 同时,大鼠要么接受三甲 (TCM) 利尿剂的治疗,要么不接受利尿剂的治疗.
主要成果:
- 在正常的盐饮食中,接受5-HT和TCM的老鼠与仅接受5-HT的老鼠相比显示出明显较低的MAP.
- 用5HT和TCM治疗的高盐饮食中的老鼠显示MAP的减少最为显著.
- 在正常食盐的老鼠中,5-HT的使用没有对或肝功能产生负面影响.
结论:
- 即使与利尿剂同时使用,5-HT在达尔- 斯斯大鼠中也表现出持续的低血压作用.
- 这些发现表明,5-HT可以作为高血压的有效补充疗法,可能克服对标准治疗的耐药性,如酸性利尿剂.
- 尽管对其他抗高血压单一疗法产生了耐药性,但5-HT的疗效仍然存在.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
38
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
38
01:16Antihypertensive Drugs: Action of Diuretics
871
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
871
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
568
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
568
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505